Epic Research

Wednesday, January 30, 2013

Epic Update : Glenmark Pharma Q3

Consolidated net profit at Rs 213 Crore Versus Rs 46 Crore (YoY)
Consolidated total income at Rs 1,381 Crore Versus Rs 1,031 Crore (YoY)
EBITDA at Rs 320 Crore Versus Rs 103 Crore (YoY)
OPM at 23.1% Versus 10% (YoY).

Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips.

No comments:

Post a Comment